ProShares UltraShort NASDAQ Biotechnology
13 hedge funds and large institutions have $5.17M invested in ProShares UltraShort NASDAQ Biotechnology in 2016 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
Holders
13
Holding in Top 10
–
Calls
$2.87M
Puts
–
Top Buyers
| 1 | +$1.36M | |
| 2 | +$784K | |
| 3 | +$411K | |
| 4 |
Jane Street
New York
|
+$334K |
| 5 |
FAM
Fred Alger Management
New York
|
+$245K |
Top Sellers
| 1 | -$215K | |
| 2 | -$79K | |
| 3 | -$36K | |
| 4 |
FTUS
Flow Traders U.S.
New York
|
-$3K |
| 5 |
HR
Howe & Rusling
Rochester,
New York
|
-$2K |